Improvement over time in outcome for children with acute lymphoblastic leukemia in second remission given hematopoietic stem cell transplantation from unrelated donors

Fagioli, F.;
2002-01-01

2002
16
11
2228
2237
Acute lymphoblastic leukemia; GVHD; HLA typing; Leukemia relapse; Unrelated donor registries; Unrelated donor stem cell transplantation; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; DNA, Neoplasm; Daunorubicin; Disease-Free Survival; Female; Graft vs Host Disease; HLA-A Antigens; HLA-B Antigens; HLA-DR Antigens; HLA-DRB1 Chains; Humans; Infant; Living Donors; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Registries; Remission Induction; Survival Rate; Time Factors; Transplantation, Homologous; Treatment Outcome; Vincristine; Hematopoietic Stem Cell Transplantation; Hematology; Oncology; Cancer Research
Locatelli, F.; Zecca, M.; Messina, C.; Rondelli, R.; Lanino, E.; Sacchi, N.; Uderzo, C.; Fagioli, F.; Conter, V.; Bonetti, F.; Favre, C.; Porta, F.; Giorgiani, G.; Pession, A.
File in questo prodotto:
File Dimensione Formato  
Improvememnt over time.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 286.1 kB
Formato Adobe PDF
286.1 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1690918
Citazioni
  • ???jsp.display-item.citation.pmc??? 14
  • Scopus 83
  • ???jsp.display-item.citation.isi??? 81
social impact